Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acyl-coenzyme A cholesterol acyltransferase 1 (ACAT1) is an enzyme involved in lipid and energy metabolism. It catalyzes the formation of acetoacetyl-CoA from acetyl-CoA, playing a role in ketogenesis and ketolysis. ACAT1 also participates in isoleucine degradation and cholesterol esterification for storage and transport. Deficiency leads to beta-ketothiolase deficiency, while elevated activity is observed in cancer. It is considered a therapeutic target for cardiovascular disease, neurodegenerative diseases, and cancer.
Inhibition of ACAT1 activity to modulate cholesteryl ester formation and/or impact tumor growth via metabolic reprogramming.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyl-coenzyme A cholesterol acyltransferase 1 (ACAT1).